M

Moderna

Develops mRNA-based medicines for health

Thought Leader Liaison - US Oncology, Commercial

Product MarketingConfirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • A bachelor's degree is required.
  • At least 8 years of experience in the pharmaceutical or biotechnology industry, including demonstrated experience in a Thought Leader Liaison or equivalent field-based commercial thought leader engagement role.
  • Oncology experience is required.
  • Ability to develop and execute strategic key opinion leader (KOL) engagement plans and build long-term relationships with influential health care professionals (HCPs) and KOLs.
  • Strong understanding of commercial compliance and regulatory requirements.
  • Ability to lead cross-functional initiatives and influence stakeholders in a complex, matrixed environment.
  • Strong analytical and strategic thinking skills, including the ability to translate complex market insights into actionable commercial recommendations.
  • Strong communication, presentation, and relationship management skills.
  • Strong organizational and project management skills, including the ability to independently manage multiple priorities and initiatives.
  • Willingness to travel extensively within the assigned territory, with travel up to 75%.

Responsibilities

  • Lead development and execution of regional KOL engagement and advocacy strategies, using market dynamics, influence mapping, and centers of excellence to set engagement priorities aligned with U.S. brand strategy and launch objectives.
  • Evaluate regional oncology market dynamics and KOL influence networks to identify strategic engagement opportunities and continually optimize regional engagement plans.
  • Identify, profile, cultivate, and maintain long-term strategic relationships with influential KOLs across medical oncology, surgical oncology, and multidisciplinary stakeholders.
  • Serve as the primary regional commercial marketing expert and contact for assigned KOLs, providing strategic guidance and coordinating cross-functional engagement initiatives.
  • Engage KOLs through on-label, compliant discussions about disease state, approved product information, and company-sponsored initiatives.
  • Develop and execute differentiated, on-label, approved KOL programming aligned with brand strategy and launch priorities.
  • Align regional KOL engagement activities across Sales, Marketing, Medical Affairs, Market Access, and Alliance stakeholders to enable coordinated and compliant execution.
  • Plan and lead KOL engagement initiatives across regional and local conferences, field visits, and other approved forums to strengthen customer relationships and advance regional advocacy objectives aligned with U.S. brand priorities.
  • Identify, analyze, and synthesize regional KOL, clinical landscape, and competitive insights, translating market information into actionable recommendations for U.S. brand strategy, positioning, and launch priorities.
  • Monitor evolving treatment paradigms, competitive dynamics, and customer needs to identify opportunities and recommend adjustments to regional commercial engagement strategies.
  • Lead regional initiatives to obtain structured KOL feedback on approved marketing materials, programs, and messaging to support optimization and future development.
  • Serve as a strategic regional resource to the U.S. Commercial Launch Lead and cross-functional Brand Team, providing oncology market expertise and actionable insights for brand strategy, launch planning, and regional customer engagement priorities.
  • Provide strategic insights and recommendations to Marketing, Medical Affairs, Market Access, and Alliance stakeholders to support integrated commercial planning and customer engagement priorities.
  • Identify and recommend appropriate HCP consultants in partnership with internal stakeholders to address evolving brand and launch needs.
  • Build familiarity with approved generative artificial intelligence and digital capabilities, exploring how these tools can accelerate compliant insight synthesis, identify patterns in complex market information, and improve strategic decision-making while maintaining human oversight and applicable compliance standards.
  • Lead planning, execution, and evaluation of regional speaker bureau and thought leader programs, setting engagement priorities aligned with U.S. brand strategy, launch objectives, and compliance requirements.
  • Identify and recommend promotional speakers based on strategic engagement priorities, regional market dynamics, and brand objectives.
  • Coordinate speaker onboarding, training, and development using approved promotional materials, including observing and coaching speakers where appropriate to support compliant program execution.
  • Oversee regional speaker program performance, evaluate effectiveness, and recommend improvements to optimize engagement outcomes and execution.
  • Lead development and execution of regional advisory board plans, coordinate cross-functional stakeholders, and translate resulting insights into actionable recommendations for brand strategy and launch planning.
  • Partner with Marketing and other internal stakeholders to support development and optimization of approved speaker materials and effective planning, execution, and follow-through of marketing-led programs.

Desired Qualifications

  • An advanced degree (MS, PhD, PharmD, or equivalent) is preferred.
  • Solid tumor oncology experience, preferably in melanoma, non-melanoma skin cancers, or non-small cell lung cancer.
  • Oncology launch experience, particularly with novel or complex therapeutic modalities.
  • Experience contributing to brand strategy and launch planning through KOL insights and regional market expertise.
  • Experience with speaker bureau management, advisory boards, and thought leader engagement programs.

About the Company

Moderna

Develops mRNA-based medicines for health

Moderna develops medicines built on messenger RNA (mRNA). Its products use mRNA delivered into cells to instruct them to produce specific proteins that can prevent or treat disease, with vaccines being a primary example. In practice, a dose delivers engineered mRNA into the body, cells translate it into a target protein, and the immune system responds or the protein modulates biology to combat disease. Moderna differentiates itself through its focus on building a whole mRNA medicines platform and in-house capabilities for designing, manufacturing, and scaling mRNA therapies, including rapid development and large-scale production. Its goal is to create a new category of medicines based on mRNA that can improve how diseases are discovered, developed, and treated, ultimately improving patient outcomes.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2010

Recently Posted Jobs

Explore more opportunities at Moderna

See more jobs